Decreased mivacurium constant infusion requirements with defasciculating doses of pancuronium

Anesthesia and Analgesia

Volumn 84, Issue 3, 1997, Pages 668-671

  Wangler, Michael D ^a   Thapar, Pankaj ^a   Skerman, Jonathan H ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; MIVACURIUM; NITROUS OXIDE; PANCURONIUM;

ADULT; ANESTHETIC RECOVERY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG POTENTIATION; ELECTROMYOGRAM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; FEMALE; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR DEPOLARIZING AGENTS; PANCURONIUM;

EID: 0031058128     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199703000-00037     Document Type: Article

References (16)

1. Lebowitz PW, Ramsey FM, Savarese JJ, Ali HH. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine. Anesth Analg 1980;59:604-9.
2. Lebowitz PW, Ramsey FM, Savarese JJ, et al. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone. Anesth Analg 1981; 60:12-7.
3. Brandom BW, Meretoja OA, Taivainen T, Wirtavuori K. Accelerated onset and delayed recovery of neuromuscular block induced by mivacurium preceded by pancuronium in children. Anesth Analg 1993;76:998-1003.
4. Rautoma P, Erkola O, Maretoja OA. Synergism between mivacurium and pancuronium in adults. Acta Anaesthesiol Scand 1995;39:733-7.
5. Erkola O, Rautoma P, Meretoja OA. Mivacurium when preceded by pancuronium becomes a long-acting muscle relaxant. Anesthesiology 1996;84:562-5.
6. Scheller MS, Zornow MH, Saidman LJ. Tracheal intubation without the use of muscle relaxants: a technique using propofol and varying doses of alfentanil. Anesth Analg 1992;75:788-93.
7. Diefenbach C, Mellinghoff H, Lynch J, Buzello W. Mivacurium: dose-response relationship and administration by repeated injection or infusion. Anesth Analg 1992;74:420-3.
8. Shanks CA, Fragen RJ, Pemberton RN, et al. Mivacuriuminduced neuromuscular blockade following single bolus doses and with continuous infusion during either balanced or enflurane anesthesia. Anesthesiology 1989;71:362-6.
9. Brandom BW, Woelfel SK, Cook DR, et al. Comparison of mivacurium suxamethonium administered by bolus and infusion. Br J Anaesth 1989;62:488-93.
10. Ali HH, Savarese JJ, Embree PB, et al. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium. Br J Anaesth 1988;61:541-6.
11. Stovner J, Oftedal N, Holmboe J. The inhibition of cholinesterases by pancuronium. Br J Anaesth 1975;47:949-54.
12. Van Der Spek AFL, Zupan JT, Pollard BJ, et al. Interactions of vecuronium and atracurium in an in vitro nerve-muscle preparation. Anesth Analg 1988;67:240-6.
13. Taylor P. Are neuromuscular blocking agents more efficacious in pairs? Anesthesiology 1985;63:1-3.
14. Waud BE, Waud DR. Interaction among agents that block endplate depolarization competitively. Anesthesiology 1985;63: 4-15.
15. Sine SM, Taylor P. Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor. J Biol Chem 1981;256:6692-9.
16. Sine SM, Kreienkamp HJ, Bren U, et al. Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of determinants of α-conotoxin M1 selectivity. Neuron 1995;15: 205-11.